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Commentary
G  protein-coupled  receptors  (GPCRs)  represent  the 
largest family of integral membrane proteins encoded by 
the human genome and detect a wide variety of ligands, 
including  peptides,  hormones,  lipids  and  nucleotides. 
They transduce extracellular signals across the membrane 
to  activate  intracellular  signaling  cascades  via  hetero-
trimeric G proteins. These consist of a Gα, Gβ and Gγ 
subunit and the precise combination of these subunits 
determines the cellular response to receptor activation. 
Additional  non-G  protein  effectors  add  layers  of  com-
plexity and diversity to GPCR signaling cascades. Due to 
their involvement in a wide variety of physiological pro-
cesses, GPCRs represent excellent pharmaceutical targets 
[1] and are the target for approximately 30% of drugs.
GPCRs do not exist in isolation in lipid bilayers, but 
instead interact with components of the bilayer, such as 
lipids and sterols, as well as with other GPCRs to form 
dimers  and  higher  order  oligomers.  It  is  likely  that,  at 
least in some cases, these dimers are of functional signifi-
cance  and  can  affect  the  ligand  binding  and  signaling 
properties  of  GPCRs  [2].  Much  recent  effort  has  been 
directed  to  elucidating  GPCR  crystal  structures  and  a 
number  of  the  structures  obtained  seem  to  indicate  the 
presence of receptor dimers. Intriguingly, the β2-adrenergic 
receptor  (β2AR)  crystalized  with  cholesterol  molecules 
and  a  post-translationally  added  palmitate  group  from 
each protomer forming most of the dimer interface [3], 
suggesting  a  role  for  lipids  and  sterols,  in  addition  to 
protein-protein  interactions,  in  GPCR  dimeri  zation. 
However, it was not clear whether this accurately repre-
sented the conformation of the dimer within native lipid 
bilayers. A recent study in BMC Cell Biology by Zheng et 
al. [4] has revealed a complex interplay between choles-
terol,  palmitate,  receptor  dimeri  zation  and  G  protein 
activation. Their study showed that reducing cholesterol 
levels  or  preventing  palmitoylation  of  the  μ-opioid 
receptor  (OPRM1)  reduced  receptor  dimerization  and 
Gα  association.  Additionally,  preventing  palmitoylation 
reduced  the  association  of  OPRM1  with  cholesterol, 
suggesting  a  functional  complex  of  receptor,  palmitate 
and cholesterol.
GPCRs and cholesterol
It has been thought for some time that cholesterol may 
play  an  important  role  or  roles  in  GPCR  signaling. 
Cholesterol is an amphiphilic sterol possessing a small 
-OH head group and a rigid four-ringed backbone; its 
size enables it to span approximately half a lipid bilayer, 
interacting with the hydrophobic tails of phospholipids. 
Cholesterol  can  alter  the  packing  of  lipids  and  thus 
increase membrane order. This has led to the hypothesis 
that cholesterol is responsible for the formation of lipid 
rafts and caveolae, regions of the membrane enriched in 
cholesterol and sphingolipids with higher order than the 
bulk  of  the  membrane.  GPCRs  have  been  found  to 
associate with both regions, and it is believed that this 
leads to an increased local concentration of receptors and 
G proteins in the laterally separated regions, increasing 
the efficiency of signal transduction [5]. In addition to 
affecting  the  properties  of  the  membranes  in  which 
GPCRs reside, it has been demonstrated that a number of 
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Due to their membrane location, G protein-coupled 
receptors (GPCRs) are subject to regulation by soluble 
and integral membrane proteins as well as membrane 
components, including lipids and sterols. GPCRs also 
undergo a variety of post-translational modifications, 
including palmitoylation. A recent article by Zheng et 
al. in BMC Cell Biology demonstrates cooperative roles 
for receptor palmitoylation and cholesterol binding in 
GPCR dimerization and G protein coupling, underlining 
the complex regulation of these receptors.
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which has led to the discovery of consensus cholesterol 
binding sites in almost half of the family A GPCRs [6]. 
The  importance  of  cholesterol  for  GPCR  function  is 
supported by that fact that addition of cholesterol or its 
analogues  can  greatly  increase  GPCR  stability  upon 
purification and also improve crystal quality. The ability 
of cholesterol to exert both direct and indirect effects on 
GPCR activity often complicates interpretation of results, 
but  in  a  number  of  cases  cholesterol  clearly  plays  an 
important  role  in  receptor  function  [6].  However,  it 
should  be  noted  that  the  effects  of  cholesterol  on  a 
particular  receptor  are  unpredictable,  and  it  has  been 
demonstrated  that  certain  GPCRs  can  function  in 
Escherichia coli membranes, which lack cholesterol [6].
GPCR palmitoylation
GPCRs are post-translationally modified in a number of 
ways, including glycosylation, phosphorylation and pal-
mitoy  lation (Figure 1). Palmitoylation is the addition of 
palmitic acid (a 16C saturated fatty acid) and occurs on 
one or more cysteines on the intracellular side of GPCRs. 
The thioester bond that links the palmitate to the cysteine 
is cleavable and thus the palmitoylation state of a receptor 
can be used to regulate its activity. It should be noted 
that, in rare cases, other lipids can be attached to GPCRs 
and that palmitoylation can occur on residues other than 
cysteine [7]. Again, the effects of palmitoylation are un-
predictable and GPCR-dependent.
Palmitoylation  influences  all  aspects  of  GPCR 
signaling.  The  palmitoylation  state  of  certain  receptors 
can preferentially direct signaling through particular G 
proteins and hence give different responses to the same 
ligand.  Up  to  three  palmitate  groups  can  be  found  on 
GPCRs and different palmitoylation profiles can result in 
various  conformations  of  the  carboxy-terminal  tail, 
which may select for certain G protein interactions [7]. 
Palmitoylation can influence the phosphorylation state of 
the  receptor,  modulating  desensitization  and  internali-
zation, and can also control internalization independent 
of phosphorylation. It has been suggested that palmitate 
binding  in  the  endoplasmic  reticulum  ensures  correct 
processing and trafficking of receptors, and, once at the 
cell membrane, may target GPCRs to lipid rafts. However, 
not all palmitoylated receptors associate with rafts and 
not all raft-associated GPCRs are palmitoylated [7]. In 
the case of OPRM1, it appears that palmitoylation and 
cholesterol association (and presumably raft interactions) 
are intrinsically linked [4].
Packed with fat
An intriguing suggestion from the structure of β2AR was 
the ability of cholesterol and palmitate to act in concert 
to mediate GPCR dimer formation [3]. It is possible that 
this  effect  was  largely  observed  due  to  crystal  packing 
conditions  but  such  an  arrangement  could  influence 
GPCR activity in vivo.
The  recent  study  by  Zheng  et  al.  [4]  systematically 
investigates the effects of cholesterol and palmitoylation 
on OPRM1 dimerization and G protein coupling using a 
variety of colocalization techniques. Cholesterol can be 
depleted by statins and Zheng et al. used the synthetic 
statin simvastatin to probe the effects of cholesterol on 
OPRM1. Simvastatin reduced the amount of cholesterol 
associated  with  OPRM1  but  also  decreased  receptor 
dimerization  and  receptor-G  protein  interactions.  The 
authors  also  demonstrate  that  mutagenesis  of  the  pal-
mitoy  lated cysteine residue in OPRM1 has no effect on 
ligand  binding  but  does  decrease  signaling  efficiency, 
probably by impairing GPCR-G protein association. The 
same mutant had significantly reduced dimerization, and 
it was proposed that this was responsible for the reduced 
G protein coupling. Although it has been suggested that a 
Figure 1. Schematic of G protein-coupled receptor post-
translational modifications and interactions. GPCRs have 
seven transmembrane domains (TMs) with an extracellular amino 
terminus and intracellular carboxyl terminus and alternating 
intracellular and extracellular loops. They undergo a variety of post-
translational modifications and interact with various components 
of the membrane. (1) The amino terminus and extracellular loops of 
receptors are often glycosylated, which can be vital for correct cell-
surface localization. (2) The carboxy-terminal tail undergoes reversible 
phosphorylation, which is important in signal desensitization and 
receptor internalization. (3) Reversible palmitoylation of cysteine 
residues within intracellular loops and the carboxy-terminal tail 
results in different loop conformations as the palmitate groups 
penetrate into the lipid bilayer. (4) Cholesterol can interact at specific 
sites within the TM helices of GPCRs, in this case TM2 and TM4. 
(5) GPCRs also may also interact with specific lipid components of the 
membrane. These interactions and modifications act in concert to 
modulate the activity of GPCRs.
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meric GPCR, monomeric receptors have been shown to 
signal  efficiently  [8],  although  this  ability  may  be 
receptor-specific. Finally, Zheng et al. demonstrate that 
the palmitate-free mutant associated more weakly with 
cholesterol  [4],  suggesting  a  functional  interaction 
between the palmitate group and cholesterol.
It is interesting to note that, in contrast to the β2AR 
crystal structure [3], the palmitate group on OPRM1 is 
not located on the carboxy-terminal tail but instead on 
the intracellular side of transmembrane domain (TM) 3 
[4].  In  β2AR,  the  dimer  interface  involves  TM1  and 
helix 8 (in the carboxy-terminal tail) whereas the OPRM1 
dimer interface is predicted to be between TM4 of each 
protomer,  with  the  palmitate  bound  to  the  carboxy-
terminal  side  of  TM3.  This  difference  in  receptor 
interface may be driven by the location of palmitoylation 
and it is possible that regulation of palmitoylation states 
could dynamically influence the dimerization interfaces 
of  GPCRs.  A  model  of  the  OPRM1  dimer  in  which 
cholesterol  and  palmitate  pack  together  to  facilitate 
receptor dimerization reveals that cholesterol inter  actions 
contribute  approximately  25%  of  the  total  interaction 
energy at the homodimer interface [4]. Dimerization of 
OPRM1  appears  to  be  regulated  by  palmitate,  which 
recruits cholesterol to stabilize the dimer. Most GPCR 
dimers are transient, and anything that affects the weak 
association  between  protomers  may  have  dramatic 
effects on the population of dimers at equilibrium.
The  complex  interplay  between  receptor,  cholesterol 
and palmitate illustrated by Zheng et al. [4] lends support 
to the model suggested by the crystal structure of β2AR 
[3] by demonstrating a role for sterols and lipids in GPCR 
dimerization in vivo. It remains to be seen if other GPCRs 
require  such  modulation  to  support  dimerization.  For 
example, neurotensin receptor 1 can dimerize in artificial 
lipid membranes even in the absence of palmitoylation 
[9] and also in low concentrations of detergent (no lipid 
bilayer)  [10].  An  interesting  discussion  remains  -  what 
truly constitutes a GPCR dimer? How close do the recep-
tors  have  to  be  to  functionally  interact?  If  a  dimer  is 
required solely to provide sufficient surface area for G 
protein coupling, then the proximity provided by such a 
lipid bridge seems sufficient, but if allosteric regulation 
by protomers within the dimer is to occur, more direct 
protein-protein interactions may be required.
These  studies  remind  us  that  it  is  vital  to  consider 
membrane proteins in the context of their environment. 
They do not exist in isolation and are heavily influenced 
by  lipids,  sterols  and  other  proteins.  Cholesterol  and 
palmitoylation can affect all aspects of GPCR activity and 
their  precise  roles  are  likely  to  be  receptor-dependent, 
although only with more data can we hope to determine 
any consensus. Membrane environments are challenging 
to control and probe, but such studies are vital if we are 
to gain a complete understanding of GPCR function.
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